Diabetology & Metabolic Diseases

It is a well-known fact that overweight (having a BMI of 30 or above) are at greater risk of developing metabolic chronic disorders like type 2 diabetes mellitus, insulin resistance. Accumulation of adipose tissue affects metabolism by secreting hormones, glycerol, and other substances including leptin, cytokines, adiponectin, and proinflammatory substances, and non-esterified fatty acids which are involved in the development of insulin resistance and disruption of fat metabolism. And the secretion of these substances will be increased leading to diabetes in obese individuals

 

  • Bariatric surgery
  • Malabsorption
  • Cardiovascular risk factors

Related Conference of Diabetology & Metabolic Diseases

June 10-11, 2024

24th Global Summit on Obesity

Dubai, UAE
June 27-28, 2024

20th Euro Obesity and Endocrinology Congress

London, UK
August 29-30, 2024

18th International Conference on Obesity Medicine

Helsinki, Finland
November 28-29, 2024

25th Annual Meet on Obesity and Diet

Bali, Indonesia

Diabetology & Metabolic Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in